Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
mstdn.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
A general-purpose Mastodon server with a 500 character limit. All languages are welcome.

Administered by:

Server stats:

14K
active users

mstdn.social: AboutStatusProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.8

#rosenberg

0 posts0 participants0 posts today
Public
Howard Smith MD, AM

Last Resort Therapy For Advanced Melanoma: Loads of Tumor Infiltrating Lymphocytes (TILs) help control tumor. #melanoma #til #tumorinfiltratinglymphocyctes #Amtagvi #lifileucel #rosenberg #nci #fda
instagram.com/p/C4L-mmcrixL/

Instagram Howard G. Smith MD, AM on Instagram: "Last Resort Therapy For Advanced Melanoma Injecting a herd of a patient’s own white cells known to kill that patient’s malignant skin cancer is effective court-of-last-resort therapy for advanced melanoma resistant to other treatments. A multi-site study of 153 with such tumors showed that this treatment known as TIL or Tumor Infiltrating Lymphocytes induced significant tumor regression in 31% of patients, complete elimination of detectable tumor in 5%, and continuing tumor control at 18 months in 42%. In response to these exciting results, the FDA has approved the use of this therapy, marketed as Amtagvi with lifileucel as the generic by Iovance Biotherapeutics, Amtagvi is not a drug but rather a process. A patient’s persistent or recurrent melanoma is surgically excised and so-called tumor infiltrating lymphocytes or TILs are harvested from the tumor. These immune T lymphocytes are then grown outside the body into a battalion uniquely capable of killing that patient’s tumor. The patient receives these cells back as a one-time injection. The entire process requires about 22 days. The processes used to capture and amplify TILs were developed at the National Cancer Institute by the ionic chief of the Institute’s Surgery Branch and head of its tumor immunology section, Dr. Steven Rosenberg. A Phase 3 randomized trial is now underway to confirm these encouraging findings to date. Meanwhile, Amtagvi is available for those who might benefit from it. The treatment isn’t cheap at about half a million dollars. TIL therapy holds great promise as yet another weapon in our growing armametarium that will capably control and vanquish all cancer…..someday soon. https://jitc.bmj.com/content/10/12/e005755 https://www.cancerhealth.com/article/fda-approves-amtagvi-new-type-immunotherapy-melanoma #melanoma #til #tumorinfiltratinglymphocyctes #Amtagvi #lifileucel #rosenberg #nci #fda"0 likes, 0 comments - drhowardsmithreports on March 6, 2024: "Last Resort Therapy For Advanced Melanoma Injecting a herd of a patient’s own white cells know..."
Replied in thread
Public
J.Sʜᴀʀᴘ🌍🇺🇦Fʀᴇᴇᴅᴏᴍ&Dᴇᴍᴏᴄʀᴀᴄʏ

@kravietz

has to tread quite the delicate line, living and working over there, and it can't be easy.

He's experienced, having lived there for so many years, and the fact that he loves as publicly as he does probably keeps him..."there", in the condition that he's in.

If you know what I mean.

Whether we like it or not, if the West wants access to russia, we cannot afford to 'not' play by their rules.

He does the best job he can, and that should be appreciated.

Public
Zeistermagazine

Stadsdichter Jan-Paul Rosenberg schreef voor het afscheid van burgemeester Koos Janssen het gedicht 'straatfeest'. Hij droeg het voor op 15 december bij het afscheidsbezoek van Koos Janssen aan De Kringloop in Zeist. Daar werd hem ook het bundeltje overhandigd met alle stadsgedichten tot nu toe.

Lees het gedicht hier: zeistermagazine.nl/straatfeest

#zeist #zeistermagazine #gedicht #stadsdichter #janpaulrosenberg #rosenberg #kringloop #burgemeester #koosjanssen #afscheid #bundel #gedichten

ExploreLive feeds
About